Skip to content
10-Q

Quarterly Report

DRUGS MADE IN AMERICA ACQUISITION CORP. DMAA DMAAR DMAAU

0001213900-25-112096

← back to feed
Filed
Nov 18, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 18, 2025 33.52M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$414.01K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$172.16K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$7.33M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$7.15M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$7.18M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$244.85K
Stockholders Equity Q3 2025 · Sep 30, 2024 −$164.86K
Stockholders Equity Q3 2025 · Jun 30, 2024 −$19.93K
Current Liabilities Q3 2025 · Sep 30, 2025 $456.61K
Current Liabilities Q3 2025 · Dec 31, 2024 $795.67K
Total Liabilities Q3 2025 · Sep 30, 2025 $7.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $795.67K
Current Assets Q3 2025 · Sep 30, 2025 $28.2K
Current Assets Q3 2025 · Dec 31, 2024 $4.99K
Total Assets Q3 2025 · Sep 30, 2025 $237.63M
Total Assets Q3 2025 · Dec 31, 2024 $550.82K
Sga Expense Q3 2025 · Sep 30, 2025 $263.7K
Sga Expense Q3 2025 · Sep 30, 2025 $726.55K
Sga Expense Q3 2025 · Sep 30, 2024 $144.93K
Sga Expense Q3 2025 · Sep 30, 2024 $199.86K
Net Income Q3 2025 · Sep 30, 2025 $2.18M
Net Income Q3 2025 · Sep 30, 2025 $5.73M
Net Income Q3 2025 · Jun 30, 2025 $2.29M
Net Income Q3 2025 · Mar 31, 2025 $1.25M
Net Income Q3 2025 · Sep 30, 2024 −$144.93K
Net Income Q3 2025 · Sep 30, 2024 −$199.86K
Net Income Q3 2025 · Jun 30, 2024 −$54.93K
Operating Income Q3 2025 · Sep 30, 2025 −$263.7K
Operating Income Q3 2025 · Sep 30, 2025 −$726.55K
Operating Income Q3 2025 · Sep 30, 2024 −$144.93K
Operating Income Q3 2025 · Sep 30, 2024 −$199.86K